21,575 Shares in Guardian Pharmacy Services, Inc. (NYSE:GRDN) Bought by Premier Fund Managers Ltd

Key Points

• Premier Fund Managers Ltd has invested approximately $435,000 in Guardian Pharmacy Services, acquiring 21,575 shares during the first quarter.
• Analysts have become increasingly optimistic about Guardian Pharmacy's stock, with several firms, including Truist Financial and Raymond James, issuing a "buy" rating and setting a price target of $28.00.
• Guardian Pharmacy Services recently reported a Q1 earnings miss of $0.21 EPS compared to analysts' estimates of $0.22, although their revenue of $329.31 million exceeded consensus expectations.

Premier Fund Managers Ltd acquired a new position in Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 21,575 shares of the company's stock, valued at approximately $435,000.

Several other institutional investors also recently modified their holdings of the stock. Brown Advisory Inc. increased its position in shares of Guardian Pharmacy Services by 0.6% in the first quarter. Brown Advisory Inc. now owns 1,602,824 shares of the company's stock worth $34,076,000 after purchasing an additional 8,870 shares during the last quarter. J. Goldman & Co LP increased its position in shares of Guardian Pharmacy Services by 1.5% in the fourth quarter. J. Goldman & Co LP now owns 762,347 shares of the company's stock worth $15,445,000 after purchasing an additional 11,263 shares during the last quarter. Nuveen Asset Management LLC increased its position in shares of Guardian Pharmacy Services by 2.9% in the fourth quarter. Nuveen Asset Management LLC now owns 547,140 shares of the company's stock worth $11,085,000 after purchasing an additional 15,550 shares during the last quarter. Franklin Resources Inc. increased its position in shares of Guardian Pharmacy Services by 2.6% in the fourth quarter. Franklin Resources Inc. now owns 513,029 shares of the company's stock worth $10,394,000 after purchasing an additional 13,029 shares during the last quarter. Finally, New York State Common Retirement Fund increased its position in shares of Guardian Pharmacy Services by 16.1% in the first quarter. New York State Common Retirement Fund now owns 323,257 shares of the company's stock worth $6,872,000 after purchasing an additional 44,709 shares during the last quarter.

Analysts Set New Price Targets

Several research analysts recently weighed in on GRDN shares. Raymond James Financial set a $28.00 price objective on shares of Guardian Pharmacy Services and gave the stock an "outperform" rating in a research report on Wednesday, May 14th. Truist Financial reaffirmed a "buy" rating and issued a $28.00 target price (up previously from $25.00) on shares of Guardian Pharmacy Services in a research note on Monday, May 19th. Finally, Wall Street Zen raised Guardian Pharmacy Services from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th.

Insider Activity

In other news, insider Fred Burke sold 138,705 shares of the stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total transaction of $2,796,292.80. Following the completion of the sale, the insider owned 413,019 shares of the company's stock, valued at approximately $8,326,463.04. This represents a 25.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider David K. Morris sold 68,547 shares of the stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total value of $1,381,907.52. Following the sale, the insider directly owned 214,495 shares of the company's stock, valued at approximately $4,324,219.20. This trade represents a 24.22% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 11,344,912 shares of company stock valued at $228,713,426. Corporate insiders own 63.71% of the company's stock.

Guardian Pharmacy Services Stock Down 2.5%

GRDN traded down $0.52 during midday trading on Friday, hitting $20.38. The stock had a trading volume of 177,798 shares, compared to its average volume of 125,387. The business has a fifty day moving average of $20.71 and a 200 day moving average of $21.47. Guardian Pharmacy Services, Inc. has a 1 year low of $14.16 and a 1 year high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.01). The business had revenue of $329.31 million during the quarter, compared to analyst estimates of $321.21 million. On average, analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.